Form 4: Upstream Bio CBO Sells Shares for Tax Obligations
Insider Transaction Report
Upstream Bio's Chief Business Officer, Adam Houghton, sold 699 shares of common stock at $9.29 per share to cover tax withholding obligations related to vested restricted stock units.
Summary
- Adam Houghton, Chief Business Officer of Upstream Bio, Inc. (UPB), reported a sale of common stock.
- The transaction involved 699 shares of common stock.
- The shares were sold at a price of $9.29 per share.
- The total value of the shares sold was approximately $6,493.71.
- Following the transaction, Adam Houghton beneficially owns 24,301 shares of common stock directly.
- The sale occurred on March 16, 2026.
- The transaction was executed under the Issuer's 'sell-to-cover' policy to satisfy tax withholding obligations associated with the vesting of restricted stock units.
- The sale was automatic and not at the discretion of the reporting person.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. A routine 'sell-to-cover' transaction for tax purposes is a standard practice for equity compensation and does not typically signal positive or negative sentiment regarding the company's fundamentals.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding Upstream Bio's future performance or strategic direction.
Management Comments
- The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person.
- The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- Such sales were automatic and not at the discretion of the Reporting Person.
Industry Context
StockSavvy.ai notes that 'sell-to-cover' transactions are common practice for executives receiving equity compensation. These sales are typically pre-arranged and non-discretionary, designed solely to meet tax liabilities upon the vesting of restricted stock units, and are generally not indicative of an insider's view on the company's future prospects or a lack of confidence.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Disclosure | Disclosure of the Issuer's 'sell-to-cover' policy, which facilitates the satisfaction of tax withholding obligations for reporting persons upon the vesting of restricted stock units. | N/A | This policy ensures compliance with tax regulations for equity compensation and provides a standardized, non-discretionary mechanism for insiders to manage tax liabilities, promoting transparency and reducing potential for misinterpretation of insider sales. |
Stakeholder Impact
- Shareholders: Minimal impact as it's a routine, non-discretionary sale for tax purposes, not indicative of a change in insider sentiment.
- Employees: No direct impact beyond the reporting person.
Key Dates
| Date | Description |
|---|---|
| 03/16/2026 | Date of transaction (sale of common stock) |
| 03/17/2026 | Date Form 4 was signed and filed |
Keywords
Upstream Bio, UPB, Adam Houghton, Chief Business Officer, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Sell-to-Cover
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.